Abstract
A novel controlled release micropump has been developed for the administration of insulin at both basal and postprandial delivery rates. Transport through a hydrophilic polyurethane foam (Hypol) provides the basal delivery, while repeated compression of the foam by the core of a solenoid augments the delivery as needed. The pump contains only one moving part, and is without any valves. It consumes power only during the postprandial delivery phase, which is a small fraction of the total delivery. Using both amaranth and insulin, the effects of pressure drop, foam length, and power input on the performance of the pump were evaluated. Although the degree of augmentation increased with decreasing basal delivery rate suggesting a stroke volume independent of basal rate, calculations based on a simple model showed that the stroke volume increased with increasing basal rate. The successful development of this delivery system will enable biomedical investigators to evaluate the relationship between metabolic regulation of glucose level and the genesis of diabetic sequelae and to assess the value of this pump in a new form of insulin therapy.
Similar content being viewed by others
Abbreviations
- A:
-
membrane area
- Cf :
-
feed concentration
- C, Ct :
-
concentration in downstream reservoir at time t
- Co :
-
concentration in downstream reservoir at t=0
- f:
-
frequency of compression
- K:
-
Darcy's law permeability
- L:
-
membrane length or thickness
- ΔP:
-
pressure difference across membrane
- Q:
-
volumetric delivery rate
- Qo :
-
basal delivery rate
- R:
-
solenoid coil resistance
- t:
-
time
- Vs :
-
stroke volume
- Vo :
-
volume of solute free solvent added to downstream reseroir prior to initiation of experiment
- ∈:
-
porosity
- μ:
-
viscosity
References
Albisser, A. M., W. S. Jackman, R. Ferguson, A. Bahoric, and Y. Goriya A portable precision pumping system for chronic programmed insulin infusion.Med. Progr. Technol. 5:187, 1978.
Albisser, A. M. and B. S. Leibel. The artificial pancreas.Clin. Endocrinol. Metab.: Diabetes. 6(2):457, 1977.
Albisser, A. M., B. S. Leibel, T. G. Ewart, Z. Davidovac, C. K. Botz, and W. Zingg. An artificial endocrine pancreas.Diabetes. 23:389–396, 1974.
Albisser, A. M., B. S. Leibel, T. G. Ewart, Z. Davidovac, C. K. Botz, W. Zingg, H. Schipper, and R. Gander, Clinical control of diabetes by the artificial pancreas.Diabetes. 23:397–404, 1974.
Bessot, M., C. Delacote, J. J. Lion, and F. Valentin. Apparatus for injection of liquid. U.S. Patent 3,850,348, November 26, 1974.
Blackshear, P. J., F. D. Dorman, P. L. Blackshear, R. L. Varco, and H. Buchwald. The design and initial testing of an implantable infusion pump.Surg. Gynecol. Obstet. 134:51, 1972.
Blackshear, P. J., T. D. Rohde, J. C. Grotting, F. D. Dorman, P. R. Perkins, R. L. Varco, and H. Buchwald. Control of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device.Diabetes. 28:634–639, 1979.
Burn, J. I. and E. Gain. The chemofusor: A new apparatus for maintaining continuous intra arterial infusion chemotherapy.Br. J. Surg. 60:375, 1973.
Cahill, G. F., Jr., D. D. Etzwiler, and N. Freinkel. Blood glucose control in diabetes.Diabetes. 25:237–238, 1976.
Chick, W. L., A. A. Like, V. Lauris, P. M. Galletti, P. D. Richardson, P. D. Richardson, G. Panol, T. W. Mix, and C. K. Colton. A hybrid artificial pancreas.Trans. Am. Soc. Artif. Intern. Organs. 21:8–14, 1975.
Corbett, J. L., J. J. Lynch, G. R. Nicol, and J. W. U. Beeston. A versatile peristaltic pump designed for grazing lambs.Lab Prac. 458–462, 1976.
Crofford, O., et al. Reports to Congress of the National Commission on Diabetes. U.S. Govt. Printing Office, Public Law 93-352, 93rd. Congress, S-2830, 1974. Findings and Declaration of Purpose. Sec. 2(a) (3), 1975.
Deckert, T. and B. Lorup. Regulation of brittle diabetics by a pre-planned insulin infusion.Diabetologia. 12(6):573–579, December 1976.
Ellinwood, E. H., Jr. Implanted medication dispensing device and method. U.S. Patent 3,692,027, September 19, 1972.
Ellinwood, E. H., Jr. Apparatus and method for implanted self powered medication dispensing having timing and evaluation means. U.S. Patent 3,923, 060, December 2, 1975.
Genuth, S. and P. Martin. Control of hyperglycemia in adult diabetics by pulsed insulin delivery.Diabetes. 26:571–581, 1977.
Goriya, Y., A. Bahoric, E. B. Marliss, B. Zinman and A. M. Albisser. Glycemia regulation using a programmed insulin delivery device. III. Long term studies on diabetic dogs.Diabetes. 28(6): 558–564, 1979.
Hargest, T. A., The negator pump for IV infusion.Biomater. Med. Devices Artif. Organs. 2:41–46, 1974.
Irsigler, K. and H. Kritz. Therapy with a portable insulin dosage-regulating apparatus.Diabetes. 28(3):196–203, 1979.
Kollsman, P. Automatic syringe. U.S. Patent 2,605, 765, August 5, 1952.
Lusher, H. M. Hydraulic permeability in hydrophilic polyurethane foams. M.A.Sc. Thesis, Department of Chemical Engineering and Applied Chemistry, University of Toronton, 1978.
Merrill, E. W. Method of administering drugs and capsule therefor. U.S. Patent 3,608,540, September 28, 1971.
Mirouze, J., J. L. Selam, T. C. Pham, E. Mendoza, and A., Orsetti. sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.Diabetologia. 14: 223–227, 1978.
Nalelz, M., J. Lewandowski, A. Werynski, and I. Zawicki, Bioengineering aspects of the artifici pancreas.Artif. Organs. 2:305–309, 1978.
Parsons, J. A., D. Rothwell, and J. E. Sharpe. A miniature syringe pump for continuous administration of drugs and hormones: The Mill Hill infusor.Lancet. Junary 8:77–78, 1977.
Pickup, J. C., M. C. White, H. Keen, J. A. Parsons and K. G. M. M. Alberti. Long term continuous subcutaneous insulin infusion in diabetics at home.Lancet. October 27:870–873, 1979.
Santiago, J. V., A. H. Clemens, W. L. Clarke, and D. M. Kipnis. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects.Diabetes. 28(1):71–84, 1979.
Spencer, W. J. For diabetics: An electronic pancreas.IEEE Spectrum. June: 38–42, 1978.
Stolzenberg, S. J. and W. H. Linkenheier. Osmotic fluid reservoir for osmotical activated longterm continuous injector device. U.S. Patent 3,604,417, September 14, 1971.
Summers, G. D. Implantable drug administrator. U.S. Patent 3,527, 220, September 8, 1970.
Sun, A. M., W. Parisius, G. M. Healy, I. Vacek, and H. G. Macmorine. The use in diabetic rats and monkeys of artificial capillary units containing cultured islets of Langerhans.Diabetes. 26:1136–1139, 1977.
Theeuwes, F. and T. Higuchi. Osmotic dispensing device for releasing beneficial agents. U.S. Patent 3,845, 770, November 5, 1974.
Thomas, L. J. and S. P. Bessman. Prototype for an implantable micropump powered by piezoelectric disk benders.Trans. Am. Soc. Artif. Intern. Organs. 21:516, 1975.
Watkins, E., Jr., Chronometric infusor — An apparatus for protracted ambulatory infusion therapy.N. Engl. J. Med. 269:850–851, 1963.
Wright, J. C., R. G. Buckles, J. T. Dunn, H. M. Leeper, and S. I. Yum. An elastomeric micrometering system for the controlled administration of drugs. Paper presented at the 111 th Meeting of the Rubber Division, ACS, Chicago, Ill., May 3, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sefton, M.V., Lusher, H.M., Firth, S.R. et al. Controlled release micropump for insulin administration. Ann Biomed Eng 7, 329–343 (1979). https://doi.org/10.1007/BF02364120
Issue Date:
DOI: https://doi.org/10.1007/BF02364120